Aflibercept monotherapy versus aflibercept with targeted retinal laser to peripheral retinal ischemia for diabetic macular oedema (LADAMO).

Elisa Eleanor CornishS WickremasingheH MehtaLyndell L LimS S SandhuV NguyenM C GilliesSamantha Fraser-Bell

Published in: Eye (London, England) (2023)

Laser to areas of ischaemic peripheral retina does not reduce the burden of intravitreal aflibercept injections when treating diabetic macular oedema.

Keyphrases

diabetic retinopathy
age related macular degeneration
optical coherence tomography
optic nerve
type diabetes
wound healing
chemotherapy induced
high speed
combination therapy
cancer therapy
open label
risk factors
endothelial cells